Xuanwu Hospital, Beijing
Clinical trials sponsored by Xuanwu Hospital, Beijing, explained in plain language.
-
New hope for stroke patients: minimally invasive clot removal tested in major trial
Disease control Recruiting nowThis study tests whether a small surgery done soon after a bleeding stroke can improve recovery. Doctors will use a thin tube to drain the blood clot and give medicine to break it up. The trial will include 750 adults with moderate to large bleeds, comparing this approach to stan…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 01, 2026 09:10 UTC
-
Light and drug combo takes aim at early Alzheimer's
Disease control Recruiting nowThis study tests whether adding near-infrared light therapy to the drug lecanemab can safely improve thinking and memory in people with mild Alzheimer's disease. About 20 participants will receive either real light therapy or a sham device along with lecanemab for 16 weeks, then …
Phase: EARLY_PHASE1 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 01, 2026 09:09 UTC
-
Could a Pre-Transfer drug boost stroke recovery?
Disease control Recruiting nowThis study tests whether giving the clot-busting drug Tenecteplase before transferring stroke patients to a specialized hospital can improve their recovery. It involves 572 adults with a major blockage in the brain's front circulation, treated within 4.5 to 24 hours of symptoms. …
Phase: PHASE3 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 01, 2026 09:09 UTC
-
New clot-buster may boost stroke recovery in major trial
Disease control Recruiting nowThis study tests whether a newer clot-dissolving drug (tenecteplase) works better than the current standard (alteplase) when given before a mechanical procedure to remove a large blood clot from the brain. About 850 adults with acute ischemic stroke will be enrolled within 4.5 ho…
Phase: PHASE3 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 01, 2026 08:55 UTC
-
Could a High-Fat diet stop seizures when drugs fail?
Disease control Recruiting nowThis study tests whether a ketogenic diet, a high-fat, low-carb eating plan, can help stop seizures in people with super-refractory status epilepticus—a life-threatening condition where seizures continue despite strong medications. About 84 adults in intensive care will be random…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Clot-Busting drug before transfer may save lives in severe stroke
Disease control Recruiting nowThis study tests whether giving a clot-busting drug (tenecteplase) before transferring patients with a severe type of stroke (basilar artery occlusion) to a specialized hospital can improve recovery. About 316 adults who had a stroke 4.5 to 24 hours earlier will receive the drug …
Phase: PHASE4 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Early surgery after stroke could save lives and reduce disability
Disease control Recruiting nowThis study tests whether performing skull surgery early—before dangerous brain swelling occurs—can improve outcomes for people who have had a severe stroke. About 380 adults aged 18 to 75 with large strokes and high risk of swelling will be randomly assigned to receive either ear…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New combo therapy aims to clear brain clots faster
Disease control Recruiting nowThis study tests whether adding a drug called batroxobin to standard blood thinners helps clear blood clots in the brain faster in people with acute cerebral venous thrombosis. About 72 adults will be randomly assigned to receive either the combination or blood thinners alone. Th…
Phase: PHASE4 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New study aims to spot Alzheimer's before symptoms start
Diagnosis Recruiting nowThis study tests a two-step approach to find early signs of Alzheimer's in 6,000 adults aged 50 and older who live in the community and have no memory problems. First, participants complete quick digital tests on a phone or computer to check thinking skills and risk. Then, those …
Sponsor: Xuanwu Hospital, Beijing • Aim: Diagnosis
Last updated May 01, 2026 09:10 UTC
-
Blood test may spot Parkinson's before symptoms worsen
Diagnosis Recruiting nowThis study aims to develop a blood test to diagnose Parkinson's disease and related disorders more accurately and earlier. Researchers will use a technique called RT-QuIC to detect misfolded proteins in blood samples from about 458 participants, including healthy controls and pat…
Sponsor: Xuanwu Hospital, Beijing • Aim: Diagnosis
Last updated May 01, 2026 08:54 UTC
-
Could a migraine medicine help Alzheimer's patients?
Symptom relief Recruiting nowThis early-stage study tests whether galcanezumab, a drug used for migraines, can help people with mild-to-moderate Alzheimer's disease. Ten participants will receive injections over 24 weeks, and researchers will measure changes in brain proteins and thinking skills. The goal is…
Phase: EARLY_PHASE1 • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated May 01, 2026 09:10 UTC
-
Ultrasound zaps brain fog in long COVID trial
Symptom relief Recruiting nowThis study tests whether a gentle ultrasound pulse to a specific brain area can improve thinking problems in people with long COVID brain fog. Researchers will compare active ultrasound to a sham (fake) treatment in 40 adults who have had brain fog for at least 4 weeks after COVI…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated Apr 30, 2026 15:49 UTC
-
New hope for Alzheimer's pain: oxycodone trial launches
Symptom relief Recruiting nowThis study tests whether a common painkiller (oxycodone with acetaminophen) can safely ease chronic pain in people with Alzheimer's disease. Ten participants will take the medication daily for 12 weeks, and researchers will monitor pain levels, daily function, and side effects. T…
Phase: PHASE3 • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated Apr 29, 2026 15:15 UTC
-
Could stem cell vesicles ease syringomyelia symptoms?
Symptom relief Recruiting nowThis early-stage study tests whether injecting tiny particles from stem cells into the spinal fluid can safely help people with syringomyelia, a condition where fluid-filled cavities form in the spinal cord. The trial includes 18 adults whose spinal cord symptoms have not improve…
Phase: PHASE1 • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated Apr 29, 2026 15:01 UTC
-
Stroke treatment window extended? new study tests late Clot-Busting drugs
Knowledge-focused Recruiting nowThis study looks back at medical records of 2,600 stroke patients to see if giving a clot-busting drug between 4.5 and 24 hours after symptoms start is safe and helpful. Researchers want to know if patients treated later can still recover well. This is an observational study, mea…
Sponsor: Xuanwu Hospital, Beijing • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC
-
New MRI scan could predict strokes before they happen
Knowledge-focused Recruiting nowThis study is testing a new MRI technique to see if it can better predict stroke risk in people with narrowed arteries in the brain (intracranial atherosclerotic stenosis). Researchers will measure blood flow pressure using a special MRI scan and track 400 participants for one ye…
Sponsor: Xuanwu Hospital, Beijing • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC